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It is a frequently debated question whether technology drives biology or whether biology
drives the development of new technologies. This issue is discussed in this manuscript as an
account that covers approximately a decade during which mass spectrometry and protein
biochemistry have intersected. It is shown that the capabilities of the mass spectrometric
methods, initially developed to address the specific need to identify proteins reliably and at
high sensitivity soon transcended the intended task. The rapid development of mass
spectrometric technologies applied to protein research has catalyzed entirely new experimen-
tal approaches and opened up new types of biological questions to experimentation,
culminating in the field of proteomics. Some conclusions from this case study relating to
technological research and the environment in which it is carried out are also
discussed. (J Am Soc Mass Spectrom 2003, 14, 685–695) © 2003 American Society for Mass
Spectrometry
During the decade of the 1990s, changes in massspectrometry (MS) instrumentation and tech-niques revolutionized protein chemistry and
fundamentally changed the way protein analysis im-
pacts biological research. These changes were catalyzed
by two technical breakthroughs in the late 1980s—
specifically, the development of the two ionization
methods, electrospray ionization (ESI) [1, 2] and matrix-
assisted laser desorption/ionization (MALDI) [3]. These
methods solved, in an essentially general way, the
difficult problem of generating ions of large, non-
volatile analytes, like proteins and peptides, to transfer
them directly into the gas phase and into the MS for
mass analysis, and to achieve all that without analyte
fragmentation [4]. Due to the lack or minimal extent of
analyte fragmentation during the ESI and MALDI pro-
cesses, they are also referred to as “soft” ionization
methods. ESI gained immediate popularity because of
the ease with which it could be interfaced with popular
chromatographic and electrophoretic liquid-phase sep-
aration techniques and it quickly supplanted fast atom
bombardment [5] as the ionization method of choice for
protein and peptide samples dissolved in a liquid
phase. Furthermore, due to the propensity of ESI to
produce multiply charged analytes, simple quadrupole
instruments and other types of mass analyzer with
limited m/z range could be used to detect analytes with
masses exceeding the nominal m/z range of the instru-
ment. For different—but no less compelling—reasons,
MALDI also rapidly gained popularity. The time-of-
flight (TOF) mass analyzer most commonly used with
MALDI is robust, simple, sensitive and has a large mass
range. Additionally, modern instruments have high
mass accuracy and resolution. Furthermore, MALDI
mass spectra are simple to interpret, due to the propen-
sity of the method to generate predominantly singly
charged ions, and the method is relatively resistant to
interference with matrices commonly used in protein
chemistry. In addition to the new ionization methods,
rapid advances in mass spectrometers and computer-
ized data processing capabilities also advanced MS
technology in general and, specifically, its application to
protein science.
The predominant goal of many applications of MS
technology was, some ten years ago, the identification
and characterization of selected, purified proteins at
high sensitivity. Rapid technical advances and changes
in biological experimentation cooperated in the emer-
gence of a new field of research termed “proteomics.”
This account attempts to describe this exciting period in
protein science and to illustrate how the interplay
between technological and biological research resulted
in quite unexpected consequences.
The story of the fruitful interaction between mass
spectrometry and protein science is by no means com-
plete. In contrast, over the last few years we have
witnessed an accelerating pace of technological ad-
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vances, breadth of questions asked and quality of
results obtained, and these developments continue un-
abated. Within the space available for this article, it is
not possible to do justice to the whole field, nor was it
the intention to produce a comprehensive review. It is
hoped, however, that the article can communicate some
of the excitement of the field to its current and future
practitioners.
Phase 1: Activity-Centered Biology
For several decades, the classical biochemical approach
has been a mainstay to study biological activities; this
strategy is schematically illustrated in Figure 1. Once an
activity is identified, a suitable assay is developed to
monitor the activity in biological samples. This assay is
used, together with sequential protein purification
methods such as salting out, ion exchange chromatog-
raphy, or size exclusion chromatography to purify the
protein catalyzing the particular activity to apparent
homogeneity. Once the protein is purified, its different
properties are studied. These include the 3-D structure,
specific activity, dependence on co-factors and, most
importantly for further experimentation, the amino acid
sequence. With the advent of the powerful methods of
molecular cloning some two decades ago, it became
sufficient, in principle, to generate limited stretches of
contiguous amino acid sequences as templates for de-
generate oligonucleotide probes for the cloning the
gene coding for the protein out of a gene library. Once
the gene was isolated, it could be rapidly and com-
pletely sequenced and used for further experimentation
into the structure and function of the protein in ques-
tion. Knowledge of the gene sequence was particularly
useful for the generation of larger amounts of the
protein by overexpression of the gene in bacteria, yeast
or other types of cells and to study the in vivo function
of the protein using the powerful methods of site-
directed mutagenesis, gene knock-out and gene re-
placement.
As many proteins could only be purified with great
difficulty and in small amounts, the major challenge for
protein chemists at the time was the development of
ever more sensitive methods to partially sequence pro-
teins. In the 1980s, the vast majority of protein se-
quences were determined by the Edman degradation, a
chemical process that removes one amino acid at a time
from the N-terminal of a polypeptide; this process was
first automatically implemented in 1967 [6]. The emerg-
ing mass spectrometric methods to sequence peptides
pioneered by Biemann and co-workers, recounted in
detail in Biemann, 2002 [7], while promising, were
initially not of comparable sensitivity and generality to
the Edman degradation. With the development of the
gas-phase protein sequencer [8], a sequencing instru-
ment was introduced that was able to sequence quan-
tities of proteins (submicrogram amounts) that were far
smaller than the milligram amounts usually purified by
the traditional method of protein purification, column
chromatography. The development of methods for the
isolation, by gel electrophoresis, of proteins in a form
compatible with gas-phase chemical sequencing, there-
fore, provided a significant increase in the overall
sequencing sensitivity. Two such methods were partic-
ularly useful. In the first, proteins separated by gel
electrophoresis were electroblotted on a solid support,
to form a replica of the protein pattern in the gel. The
protein spots, once detected by staining, could be
excised and directly transferred into a sequencer [9, 10].
The second method, a variation on the theme, addition-
ally involved tryptic digestion of the electroblotted
proteins on the solid-support and the recovery and
separation of the thus generated peptides (Figure 2).
Selected peptides were then purified by reverse-phase
HPLC and sequenced [11]. In effect, this method pro-
vided a peptide mixture from very small (microgram
and submicrogram) amounts of proteins and was there-
fore a useful pre-cursor for the popular peptide mass
mapping techniques developed a few years later. The
method also provided a general solution to obtaining
partial sequence information of all those proteins that
contained N-terminal modifications that made them
refractory to the Edman degradation.
A typical example illustrates the principle and the
status of the technology in the mid 1980s. A heroic effort
in protein purification by the group of Paul Patterson at
Caltech had resulted in a sample that contained very
low microgram amounts of a highly enriched activity
defined as Cholinergic Differentiation Factor (CDF): A
protein that was responsible for inducing a crucial
differentiation step in the development of the mamma-
lian nervous system. By applying the electroblotting, in
Figure 1. Schematic representation of activity-centered biology.
An activity, typically catalyzed by a protein or a protein complex
is purified to apparent homogeneity by a series of cycles of sample
fractionation and assay for the activity in question. The target
activity is indicated as a filled feature and proteins in the sample
that are unrelated to the target activity are indicated as open
features.
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situ tryptic cleavage and peptide sequencing method,
we were able to obtain partial sequence information
from the purified activity [12]. Surprisingly, the ob-
tained peptide sequences matched perfectly to a previ-
ously identified protein called leukemia inhibitory fac-
tor (LIF), a protein that later became important for
maintaining embryonic stem cell lines used for the
generation of transgenic mice in an undifferentiated
state [13]. Further careful analyses of LIF and CDF—in
particular, the comparison of the complete respective
gene sequences—indeed conclusively indicated that the
same protein carried out both activities. This example
illustrates a number of characteristics of an activity-
centered biology. First, the method critically depends
on the availability of a suitable assay to follow the
purification of the activity. In the case of CDF, this was
a cell-based assay for which the read-out was obtained
after several days. The generation and purification of
the factor at an amount compatible with sequencing
was a project of several months duration. Furthermore,
proteins with no measurable activity or with an activity
for which no assay could be developed, were outside
the scope of the approach. Second, using gel electro-
phoresis as the final purification step was a major
advance in the field, because the target protein no
longer needed to be purified to homogeneity. It was
sufficient to prepare a sample in which the target
protein was highly enriched and corresponded to a
defined electrophoretic band. Third, the protein se-
quence provided the link between the protein and the
gene sequence and conclusively identified the activity
under investigation and, as illustrated by the chosen
example, it was not unusual to find proteins carrying
out more than one defined activity. This multitasking of
proteins was later appropriately termed “protein moon-
lighting” [14]. And fourth, the approach was reduction-
ist; every activity was isolated and studied in isolation,
and—a major goal of biochemical projects—the recon-
struction of whole biological processes in vitro from the
isolated components only rarely succeeded.
The challenges of the activity based biology for the
analytical protein chemist were mainly related to ob-
taining stretches of uninterrupted amino acid sequence
from ever decreasing amounts of protein. While of great
practical utility, these methods did not represent a
significant advance, conceptually. They were intended
to obtain the sequence of purified proteins faster and
more sensitively and therefore to support a traditional
and well-developed approach to study biological sys-
tems.
Phase 2: From an Activity-Centered
to a Sequence-Centered Biology
Using the electroblotting/microsequencing methods
described above, in 1987 we succeeded in obtaining
partial amino acid sequences of proteins separated by
high-resolution two-dimensional gel electrophoresis (2-
DE) [11, 15]. These results attracted a considerable
amount of interest because they provided the key for
the development of an approach that deviated substan-
tially from the biochemical research method described
above. 2-DE was developed in the 1970s independently
by Klose [16] and O’Farrell [17] as a gel electrophoretic
method for the separation of proteins at high resolution.
In the most common implementation of the technique,
proteins are separated by isoelectric focusing in a first
dimension and then by SDS polyacrylamide gel electro-
phoresis (SDS-PAGE) according to their size in a second
dimension. The separated proteins are then detected by
staining and the staining intensity provides an estimate
Figure 2. Schematic representation of the process for the generation of peptide fragments from small
quantities of protein separated by 2-DE as described in [11]. A protein sample mixture is separated by
2-DE and the proteins are electroblotted onto a nitrocellulose membrane and stained. Specific protein
spots are excised from the membrane and the proteins are digested on the membrane, typically with
trypsin. The generated peptides are recovered and separated by reverse-phase HPLC and collected for
sequencing. In later uses of the method the peptides were directly analyzed by MS or MS/MS for the
purpose of identifying the protein(s) contained in the spot analyzed.
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of the quantity of the protein present in each detected
spot. It was soon recognized that highly reproducible
protein patterns could be generated and that, therefore,
the spot patterns from different samples could be
overlaid and compared, providing a general method to
perform subtractive analysis of the proteins contained
in two or more samples. Using this method, proteins
that were likely to be related to a particular biological
process could be detected among hundreds of detected
features.
Based on such 2-DE protein profiles, ideas were
developed in the 1970s and 1980s, to build protein
databases (e.g., the human protein index) [18] and to
apply strategies based on subtractive pattern analysis
[19–21] akin to today’s popular strategies for the anal-
ysis of data obtained from gene expression array exper-
iments. In fact, at that time many of the principles now
commonly used for global, quantitative analysis of gene
expression patterns, such as the use of clustering algo-
rithms and multivariate statistics, were developed in
the context of 2-DE [22, 23]. At that time, however, these
ideas were not substantially implemented, mainly be-
cause 2-DE by itself was an essentially descriptive
technique that did not indicate the identity of the
separated proteins. The ability to identify proteins from
2-D gels provided the required link between the ob-
served protein pattern and the sequence of the proteins
constituting interesting patterns. Therefore, subtractive
2-D gel pattern analysis could now serve as the assay to
identify proteins that seemed to be part of a biological
process and these proteins could be sequenced before
their function or activity was known.
The following example illustrates the approach and
highlights some of its limitations. In collaboration with
John Leavitt, then at the Linus Pauling Institute, we
performed comparative analysis of 2-D gel protein
patterns of two human fibroblast cell lines. The control
cell line was a normal fibroblast cell line and the sample
cell line had been chemically transformed. It was ex-
pected that subtractive analysis of the protein patterns
extracted from the two cell lines would identify protein
differences and that these differences were related to
the chemical transformation. Figure 3 shows a section of
the silver stained 2-D gels from the control and trans-
formed cell line, respectively, and indicates that the
expected pattern differences indeed were observed. The
protein spot marked lpl in Figure 3 was clearly present
in the transformed fibroblasts but absent in the control
cells. The protein was identified by sequencing as
plastin, a protein now known to be involved in the
organization of the actin network [24]. The attraction of
this approach lies in the fact that complex biological
processes such as cell transformation could be studied
at the protein level without the need for an assay to
probe for a specific activity. In fact, no hypotheses as to
which proteins might be involved in the process were
required. The limitation of the sequence first approach
was the difficulty of identifying the molecular and
cellular function of the proteins that were identified. A
further limitation of the approach as described was also
the limited dynamic range of protein abundance that
could be explored by the 2-D gel method [25] and the
slow and relatively insensitive protein identification by
chemical sequencing.
For the analytical chemist, the challenges of the
activity-based and sequence-based biology remained
similar and were mainly related to the task of conclu-
sively identifying proteins with increasing sensitivity
and speed. For the biologist, the main challenge posed
by the sequence-centered approach was that s/he was
frequently confronted with a large list of seemingly
important observations, e.g., proteins, the abundance of
which changed under specific experimental conditions;
such data are difficult to interpret in a biological con-
text. Conceptually, the process described above marked
a significant departure from the traditional protein
biochemical approach because no specific hypothesis
and the development of no specific assays were needed
to study a particular question. This development illus-
trates that the application of an established technique in
a different manner can have a significant impact on the
experimental approach used and on the questions
asked. These developments also pioneered the idea that
the large-scale analysis of gene expression patterns
contained a wealth of useful information, an idea that
was later very successfully emulated by gene expres-
Figure 3. Identification of plastin by subtractive 2-DE [15]. A
section of silver stained 2-DE gel patterns of proteins extracted
from normal fibroblasts (A) or from transformed fibroblasts (B) is
shown. Within a pattern of spots common to both samples a
doublet of spots marked with lpl is clearly up regulated in the
pattern of the transformed cell. The protein was identified as L
Plastin by microsequencing. A related protein T Plastin tpl ap-
peared unchanged under the conditions examined. This example
illustrates the sequence first approach to identify proteins in-
volved in complex physiological functions without the need for a
specific biochemical assay.
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sion array technologies and used with great success
[26]. Before the systematic, large-scale analysis of the
proteins present in a complex sample could be routinely
applied, much improved analytical technologies were
needed. It was in this context that in 1994, at the first
2-DE meeting in Siena, Italy, the term “proteome” was
coined [27]. The term was defined as the protein com-
plement of the genome, and the process of studying the
proteome was soon thereafter called “proteomics” and
mass spectrometry was its most important component.
From First to Second Generation
Proteomic Technologies
In the early 1990s, a bewildering array of methods were
developed that had the common goal of identifying
proteins separated by gel electrophoresis rapidly and
sensitively [28]. These methods were the result of a
convergence of rapidly improving MS technologies,
most notably the development of the ESI and MALDI
ionization methods that were capable of routinely ion-
izing even large polypeptides, the availability of se-
quence databases with rapidly increasing contents, and
the development of computer search algorithms that
were capable of correlating mass spectrometric infor-
mation obtained from single peptides or from the
collective peptide mixture generated by the digestion of
a protein with sequence databases, thus identifying
proteins without the need for de novo sequencing.
While the methods differed in detail, two main proce-
dures could be distinguished. The first is known as
peptide mapping, peptide mass mapping, or peptide
mass fingerprinting. In this method, the match of a list
of experimental peptide masses with the calculated list
of all peptide masses of each entry in a database (e.g., a
comprehensive protein database), identifies the protein.
Five groups almost coincidentally developed computer
tools for the identification of proteins by peptide map-
ping [29–33]. Since mass mapping requires an essen-
tially purified target protein, the technique has been
commonly used in conjunction with prior protein frac-
tionation by 2-DE. This method, which is mainly
carried out with MALDI-TOF mass spectrometers is
still widely used today. In the second procedure,
protein identification was based on sequence infor-
mation generated from selected peptides in a tandem
mass spectrometer. Since the information contained
in collision-induced dissociation spectra (CID) is not
readily convertible into a full, unambiguous peptide
sequence, the CID spectra are scanned against com-
prehensive protein sequence databases using one of a
number of different algorithms of which Sequest is
the prototypical tool [34]. It rapidly became apparent
that a strictly 2-DE-based proteomics technology plat-
form was technically complex, labor- and therefore
cost-intensive and fundamentally limited as shown
below. The increased use of MALDI-MS and ESI-
MS/MS for the identification of 2-DE separated pro-
teins also led to the realization that the incidence of
co-migration of proteins even in this, the highest
resolving protein separation method known, was
more prevalent than first thought [25, 35]. Since
quantification in 2-DE relies upon the assumption
that one protein is present in each spot, co-migration
compromises such analyses. It was also observed that
with conventional protein staining methods, only a
relatively small subset of a cellular proteome is
apparent if unfractionated cell lysates are separated
[25, 36]. Therefore, in spite of its maturity and un-
matched performance for separating intricate pat-
terns of differentially modified and processed pro-
teins [37], and in spite of continued evolution of 2-DE
separation and detection technology, alternative
methods for large-scale protein expression analysis
began to be more vigorously investigated.
Analyzing peptides extracted from MHC class I
and class II proteins, Hunt and colleagues laid the
groundwork for a gel-independent approach to pro-
teomics by demonstrating the ability of LC-MS/MS
systems to handle extremely complex peptide mix-
tures [38], and it is this method that is today at the
core of mass spectrometry-based proteomics. How-
ever, before LC-MS/MS could be used for both the
identification of protein mixtures and for quantitative
proteomic experiments, a number of technical issues
had to be addressed, the main one being the inher-
ently poor correlation between the quantity of an
analyte present in a sample and the signal intensity
generated for that analyte. To add a quantitative
dimension to peptide LC-MS/MS experiments, we
applied the proven technique of stable isotope dilu-
tion [39] to proteome analysis. Stable isotope dilution
makes use of the fact that pairs of chemically identical
analytes of different stable isotope composition can
be differentiated in a mass spectrometer, due to their
mass difference, and that the ratio of signal intensities
for such analyte pairs accurately indicates the abun-
dance ratio for the two analytes.
To generate pairs of labeled peptides, we synthe-
sized a class of reagents termed “isotope coded affinity
tags” (ICAT) reagents and a mass spectrometric method
for gel-independent quantitative proteome profiling
[40]. The structure of the reagents and the method are
schematically illustrated in Figure 4. ICAT reagents
consist of three functional elements: a thiol reactive
group for the selective labeling of reduced Cys residues,
an isotopically coded linker in an isotopically normal
(d0) or heavy (d8) form and a biotin affinity tag to allow
for selective isolation of labeled peptides. A typical
experiment is schematically illustrated in Figure 5. The
disulfide bridges of the proteins contained in the sam-
ple are reduced under denaturing conditions, and the
free sulfhydryl groups of the proteins from the two
related samples to be compared are labeled with the
isotopically light and heavy forms of the reagent, re-
spectively. The samples are then combined, proteolyzed
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with trypsin, and the resulting peptides can be sepa-
rated by any number of optional fractionation steps,
including the removal of untagged peptides (i.e., not
containing a Cys residue) via avidin affinity chroma-
tography. Peptide/protein identifications are finally
made by MS/MS analyses of the individual fractions
followed by sequence database searching the observed
MS/MS spectra. The observed ratio of the signal inten-
sities for the unfragmented, isotopically light and heavy
forms of the same peptide finally yields the relative
abundance of that peptide, and hence the protein from
which it was derived, in the original samples.
Results from a series of applications of the method
have illustrated its versatility, documented current
technical limitations and showed new uses for quanti-
tative proteomic analyses. The applications can be
broadly grouped into three classes. In the first, quan-
titative proteomics was used to ask whether the
analysis of perturbation-induced changes measured
at the mRNA and protein levels provide redundant or
complementary information [41, 42]. In the second
class, quantitative proteomics was used to gain new
insights into specific cellular mechanisms [43– 45] and
in the third class, applications that use quantitative
proteomics for purposes that go beyond simple pro-
tein profiling were explored. These include the appli-
cation of the technique for the analysis of macromo-
lecular complexes [46] and for the systematic analysis
of protein phosphorylation [47, 48]. Two of the ac-
companying papers in this volume [49, 50] illustrate
typical applications of the ICAT reagent-based quan-
titative profiling method.
Figure 4. Structure of isotope coded affinity tag (ICAT) reagents. The groups designated with X in
the linker indicate the location at which stable heavy isotopes are incorporated into the reagent. In the
initial reagents [40] the heavy isotope was deuterium. In second generation reagents the H/D isotope
pair was replaced with 12C/13C.
Figure 5. Schematic representation of typical ICAT experiment for quantitative protein profiling.
Two protein mixtures are treated with the isotopically light and heavy ICAT reagents, respectively.
The labeled protein mixtures are then combined and proteolyzed, tagged peptides are selectively
isolated by avidin affinity chromatography and analyzed by MS and MS/MS. The relative abundance
is determined by the ratio of signal intensities of the tagged peptide pairs. Every other scan in the mass
spectrometer is devoted to fragmenting a peptide. The CID spectra are recorded and searched against
large protein sequence databases to identify the protein. Therefore, in a single operation, the relative
abundance and sequence of a peptide are determined. The peptide samples analyzed can include cell
lysates or fractions thereof. Specifically, proteins in subcellular fractions including microsomes [45],
secreted proteins, proteins in protein complexes [46], and proteins in body fluids such as serum have
been analyzed by the method.
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From a Sequence-Centered Biology
to Systems Biology
Above, we identified as one of the major challenges of a
sequence-based biology the common situation that a
biologist is faced with a long list of seemingly interest-
ing observations, i.e., proteins that change in their
abundance under specific experimental conditions and
that are difficult to explain in biological terms. Cur-
rently, the investigator is forced to select, based on
experience, references in the literature, or arbitrarily,
one or a few of these observations to carry out valida-
tion and follow-up experiments to eventually publish a
report on the findings related to that protein or a
selected group of proteins. This is process is illustrated
by two accompanying papers in this volume [49, 50].
While this approach is successful, it suffers from the
obvious disadvantage that all those observations that
are not followed up are essentially lost, even though
they might also contain very useful information. It has,
therefore, become apparent, that new approaches are
required to fully exploit the emerging capacity to collect
large sets of quantitative data using the proteomic
technologies discussed above. A recent study carried
out in the yeast S. cerevisiae points towards a possible
solution of the data interpretation problem [41]. The
principle of the approach is illustrated in Figure 6. In
this study, both genomic and proteomic data were
collected from yeast cells in which all the known
components of the galactose induction pathway had
been systematically perturbed or eliminated by targeted
gene knock out, or by metabolic stimulation. The dif-
ferent types of data, systematically collected, were in-
tegrated into a mathematical model consistent with the
available information. This model was then used to
predict new, previously unknown interactions within
the pathway and between the galactose induction path-
way and other cellular processes. Some of these predic-
tions were subsequently verified experimentally [41].
The study revealed the striking observation that pertur-
bations in this seemingly simple and relatively confined
process that consists of nine core elements resulted in
changes in the expression of close to 1000 yeast genes,
indicating that this systematic approach has the poten-
tial to indicate connections between cellular processes
that are difficult to determine by the traditional reduc-
tionist research methods. The systematic approach de-
Figure 6. Schematic illustration of method for the analysis of complex biological systems using large
data sets obtained by systematic genomic and proteomic measurements (adapted according to [41].
Cells are subjected to targeted perturbation of selected elements of the system studied. The perturbed
sample is subjected to quantitative, systematic measurements and the data obtained are explained
within the framework of a model of the process studied. The model is used to make predictions about
the expected effects of each perturbation. The predicted and measured effects are reconciled and the
perturbation/analysis cycle is continued until the measured and predicted patterns converge.
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veloped in this study is based on the seemingly para-
doxical position that it is easier to interpret the
information contained in multiple large datasets than in
a single one.
For the researcher who plans to apply this iterative
approach to systematically study biological processes,
several challenges are immediately apparent. First, the
capacity to generate large proteomic data sets needs to
be available. Currently, every large-scale quantitative
proteomic profiling experiment is a major effort requir-
ing several days of mass spectrometer time and count-
less hours of data analysis. Second, the data from
different experiments can only be meaningfully com-
pared if the quality of the data is known, consistent and
verifiable. Currently, the identification of proteins in
most published proteomic data sets involve at least
partial manual interpretation and are thus expected to
be inconsistently scored. To make data interpretation
portable and transparent, it will minimally be necessary
to develop algorithms that assign a score to each
observation, such as peptide or protein identification or
quantitative ratio, that estimates the probability that the
observation is correct, independent of experimental
variables such as the type of instrument used to gener-
ate the data, the database search tool used, or the
quality of the sample. The recently developed computer
tools PeptideProphet [51] and ProteinProphet [52]
(see also http://www.systemsbiology.org/Default.
aspx?pagenameproteomicssoftware) address these
needs and will be useful to rigorously test whether
large proteomic data sets can be consistently and trans-
parently analyzed. Third, the data need to be organized
in relational databases and software tools need to be
developed for higher order analyses such as hierarchi-
cal clustering and multivariate statistics; and fourth, the
capabilities of generating high quality quantitative pro-
teomic analyses need to become readily accessible to
broadly impact biology and medicine.
Ordered Peptide Arrays: A Path
to the Future?
The sample throughput of the current LC-MS/MS
based proteomics technology is mainly limited by the
need to de novo identify every peptide/protein in each
experiment. This is currently accomplished by peptide
mass fingerprinting and increasingly, by tandem mass
spectrometry and sequence database searching. Pro-
teomics, therefore, currently operates in a perpetual
“discovery mode” in which the observations made
prior to a current experiment are disregarded. The
genome projects have taught us that the universe of
observable biological events in a species, e.g., the num-
ber of different proteins produced, is large but finite.
Therefore, once all the possible proteins within a species
have been discovered and described, proteomics will be
transformed from a discovery mode of identifying and
describing proteins, to a ‘browsing’ mode, in which the
universe of possible events is searched for constella-
tions that correlate with a particular state or function.
Genomics-style biology, including proteomics, can be
separated into two distinct phases, a discovery phase to
characterize the universe, and a browsing phase, in
which system-wide biological assays search the uni-
verse. To reach its potential as a high impact, high
throughput technology, proteomics needs to advance
from a discovery mode to a browsing mode of opera-
tion.
Fortunately, it is possible to suggest a browsing
technology for proteomics. The following proposed
scheme is conceptually simple and schematically illus-
trated in Figure 7. For each protein, protein isoform or
specifically modified form of a protein, a peptide se-
quence that is idiotypic (or uniquely identifies) for that
polypeptide is selected, chemically synthesized and
labeled with tags of a heavy stable isotope. These
peptides are therefore definitive markers for the pro-
teins to be studied. Precisely measured amounts of
these reference peptides are then added to a sample in
which the proteins or peptides have been labeled with
tags of a light stable isotope. The combined peptide
sample can be separated reproducibly, and fractions
deposited on the sample plate of a mass spectrometer,
effectively generating an ordered peptide array. Each
array element can then be interrogated by a mass
spectrometer and will generate two types of signals: one
representing the signals of the peptides for which no
reference peptide has been added - appearing as single
peaks, and the other representing the signals for those
peptides for which a reference peptide was added—
appearing as paired signals with a mass difference that
precisely corresponds to the mass differential encoded
in the stable isotope tag. In this method, a protein is
identified by correlating the position and the accurately
measured mass of each isotope-peptide pair in the
array. Proteins are quantified by determining the ratio
of the size of the signal of a peptide derived from the
protein mixture with the signal of the corresponding
reference peptide.
There are several advantages of this proteome
browsing method. First, one peptide is sufficient for the
unambiguous identification and quantification of each
protein. Therefore, the number of peptides that need to
be analysed to identify and quantify the product of
every gene approaches the number of genes in a ge-
nome. Second, data analysis becomes trivial because
each protein is identified and quantified by correlating
the acquired data with a look-up table, rather than by
de novo sequencing. Third, the method is easily stan-
dardized between laboratories. Fourth, the absolute
quantity of each protein is determined, thus making
data sets easily comparable. Fifth, any subset of pro-
teins, for example, proteins contained in organelles,
sub-cellular fractions or differentiated cells, can be
selectively interrogated. Sixth, splice isoforms, differen-
tially modified or processed proteins, can similarly be
absolutely quantified, provided that appropriate refer-
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ence peptides can be synthesized. Finally, the method is
relatively cheap, as only minuscule (nanogram to sub-
nanogram) amounts of the peptide standards are used
per assay. However, similar to other genomics technol-
ogies, the proposed proteomics technology requires a
sizable initial cost and labour investment that will pay
dividends by the wide dissemination of a rapid, robust
and simple quantitative technology. The initial invest-
ment is required for the synthesis and calibration of
thousands of isotopically labeled peptides. A project of
this scope not only exceeds the scope of a typical
laboratory, but mandates a collaborative approach,
since if different research groups were to generate their
own sets of reference peptides, correlation of data
between studies would be difficult. It can be expected
that such a robust, simple and quantitative proteomics
technology will have the sample throughput required
to carry out measurements on differentially perturbed
cell for carrying out clinical studies, and therefore to
realize the potential of proteomics.
Conclusions
“Does technology development drive biology or does
biology drive the development of new technologies”
was the question posed at the outset of this manuscript.
Using the development of advanced mass spectrometric
techniques and their application to protein based bio-
logical research as an example, it was illustrated that
there is no clear answer since the interplay of biology
and technology development is complex. Protein iden-
tification via MS was initially used to better support the
biochemical, activity-based research method than had
been possible with the traditional protein sequencing
methods. By combining these increasingly sensitive
protein identification tools with high resolution 2-DE, a
new research strategy was created that no longer relied
on the availability of assays for specific activities. In
fact, the protein pattern displayed in the 2-D gels, if
subjected to comparative pattern analysis, could by
itself be used as an assay to probe complex biological
processes, and the strategy of systematically studying
the proteins expressed in a sample was termed “pro-
teomics.” Limitations in the 2-D gel based approach to
quantitative proteomics led to the development of sec-
ond generation proteomic techniques, notably the ICAT
reagent technique in conjunction with tandem mass
spectrometry. Furthermore, the challenge of interpret-
ing the large amounts of data generated by proteomic
studies in terms of biological function catalyzed the
Figure 7. Schematic representation of ordered peptide array technology for quantitative proteomics.
A protein sample is labeled with stable isotope tagging reagents (e.g., light reagent) and processed to
generate a sample of isotopically tagged peptides (left branch). Concurrently, a reference peptide
sample consisting of calibrated, isotopically tagged (e.g., heavy reagent) synthetic peptides is prepared
and added to the peptide sample derived from the protein sample (right branch). The reference
peptides are selected such that each target protein is represented by one or more idiotypic peptides.
The combined peptide sample is fractionated by 1-D, 2-D, or 3-D chromatography and spotted onto
the sample plate of a MALDI mass spectrometer. MS analysis of the resulting ordered array (insert)
indicates that each sample spot contains multiple peptide signals of two types. The first type of signal
is a singlet and represents a peptide that is either a protein-derived peptide for which no reference
sample was added (usual case) or a reference peptide for which no protein-derived peptide was
detected (rare case). The second type of signal is a doublet of which one peak represents the calibrated
reference peptide and the other peak represents the protein-derived peptide. Focusing the analysis on
the doublets rapidly and conclusively identifies and absolutely quantifies proteins contained in the
sample mixture.
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development of a new strategy that is based on the
comparative analysis of systematically collected data
sets from differentially perturbed cells. As this strategy
requires the repeated analysis of substantially identical
samples, it seemed inefficient to de novo discover each
protein in each experiment, and we propose to enter
into a “browsing” mode of proteomics with the poten-
tial to generate accurately quantitative data at very high
throughput.
This interrelatedness of technology and biology re-
search also has important implications for the working
environment in which successful work is being carried
out. It follows that technologies with an early and large
impact on biology are best developed in a culture in
which important problems posed by biology are appar-
ent and understood. It also follows that the research
should be carried out in an environment in which
biologists are being made aware of emerging technical
capabilities to advance their research. In short, it ap-
pears that an integrated, multidisciplinary research
environment provides a fertile ground for advancing
high impact technologies as well as for pioneering
advances in biology. How such environments are being
created is, of course, another question altogether.
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